Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT03240757 Completed - Clinical trials for Metabolism and Nutrition Disorder

Metabolic and Functional Impact of Various Breakfast Models

Start date: July 14, 2009
Phase: N/A
Study type: Interventional

In the present study the investigators compared the hormonal and metabolic effects of three meal loads very popular among Italian eating habits, both in the resting- and exercising state. Given the lack of time is considered a common barrier to exercise adherence, we wanted to identify a low dose of exercise capable to produce health benefits in the post-absorptive status elicited by three commonly consumed meal-models in Mediterranean countries. To this end, healthy young volunteers firstly underwent an oral glucose tolerance test (OGTT) and three meal tolerance tests. Secondly, in an extra set of experiments, subjects cycled at low intensity for the last 20 minutes of the same glucose/meal tolerance test. Glycemia, insulinemia, ghrelinemia, lipidemia, and satiety were measured throughout OGTT and each test-meal load.

NCT ID: NCT03240575 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

The ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a Combination of Fluticasone and Salmeterol Taken Using the Diskus

Start date: August 14, 2017
Phase: Phase 4
Study type: Interventional

The primary objective of the trial is to show superiority in lung function of once daily (2 inhalations) treatment with orally inhaled tiotropium+olodaterol fixed dose combination to twice daily (one inhalation) treatment with fluticasone propionate+salmeterol fixed dose combination over 12 weeks in patients with Chronic Obstructive Pulmonary Disease (COPD). A Digital Health (DH) exploratory study has been integrated into the main study as a site specific study. The DH exploratory study will be performed at a single site; the site is also participating in the main study. The DH exploratory study site will enter (randomize) approximately 20 patients (subjects) (in addition to the patients to be enrolled in the main study at this site). The patients enrolled in the DH exploratory study are not considered to be part of the main study (i.e. data collected in the DH exploratory study will be analyzed separately from the data collected in the main study).

NCT ID: NCT03240419 Completed - Inflammation Clinical Trials

Prenatal Probiotic Intervention

Start date: August 23, 2017
Phase: N/A
Study type: Interventional

This study will assess the feasibility of a randomized control trial in which the effects of probiotic supplementation throughout pregnancy on maternal insulin sensitivity and inflammation, as well offspring gene expression and body composition are examined.

NCT ID: NCT03239769 Completed - Clinical trials for Differentiated Thyroid Carcinoma (DTC)

Compare the Aesthetic Effect of Different Thyroidectomies

Start date: June 1, 2012
Phase: N/A
Study type: Interventional

One hundred twenty female patients who underwent thyroidectomy were evenly distributed into three groups: conventional access (CA), aesthetic principles access (APA) and minimally invasive access (MIA). The Patient and Observer Scar Assessment Scale (POSAS) was used as the assessment tool for the linear scar. After one year follow-up, the cosmetic outcomes were assessed.

NCT ID: NCT03239379 Completed - Clinical trials for Safety and Tolerability in Healthy Subjects

A Multiple-Dose Study of Intravenous BNZ132‑1-40 in Healthy Adult Subjects

Start date: October 30, 2017
Phase: Phase 1
Study type: Interventional

This study is a single-center, randomized, single‑blind, placebo (PBO)-controlled, multiple-dose study to characterize the safety, tolerability, PK, and PD of IV BNZ-1 administered to healthy adult subjects once weekly (QW) for 4 doses or once every other week (QOW) for 3 doses. Five cohorts of 6 subjects randomized 5 BNZ-1:1 PBO are planned to be enrolled in the trial. Participants will be followed for 4 weeks after the last dose for safety monitoring, and collection of PK and PD samples.

NCT ID: NCT03239340 Completed - Clinical trials for EGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer

A Molecular Profiling Study of Patients With EGFR Mutation-positive Locally Advanced or Metastatic NSCLC Treated With Osimertinib

ELIOS
Start date: May 30, 2018
Phase: Phase 2
Study type: Interventional

A multicentre, open-label, single-arm, molecular profiling study of patients with EGFR mutation-positive locally advanced or metastatic NSCLC treated with osimertinib.

NCT ID: NCT03239275 Completed - Clinical trials for Malocclusion, Angle Class II, Division 1

Clinical Evaluation of Bio-creative Therapy for En Masse Retraction of the Maxillary Anterior Teeth

Start date: January 17, 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the effectiveness and efficiency of labial versus lingual biocreative therapy in achieving en masse retraction of the maxillary anterior teeth in subjects with class II malocclusion requiring upper first premolar extraction.

NCT ID: NCT03239223 Completed - Cervical Cancer Clinical Trials

Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection

Start date: January 1, 2018
Phase: Phase 1
Study type: Interventional

This study evaluates the use of topical ABI-1968 cream, in the treatment of cervical precancerous lesions in adult women.

NCT ID: NCT03239002 Completed - Clinical trials for Fetus; Abnormal, Affecting Management of Pregnancy

Antenatal Detection by Array CGH Genomic Rearrangements Unbalanced Front Uninsulated Thick Neck or a Combination of Two Signs of Ultrasound Calling Normal Karyotype

CGH Array
Start date: July 2011
Phase: N/A
Study type: Observational

This is the first study with a real diagnostic and prognostic focus in prenatal. In addition to this innovative aspect, the identification of cryptic imbalances in fetuses with malformative syndrome would be an invaluable resource for the identification of new genes involved in development, as is already the case for postnatal studies. This research aims to: 1. to test the feasibility of this protocol, ie the practical application of this new technology in the context of prenatal diagnosis, 2. demonstrate and evaluate the possible involvement of cryptic chromosomal abnormalities in fetuses with a thick neck associated with other malformations and recruited on the strict criteria mentioned above, 3. assist in the diagnosis of these fetuses and genetic information for their families, 4. identify new regions of the genome potentially involved in the occurrence of congenital malformations.

NCT ID: NCT03238781 Completed - Clinical trials for Chronic Migraine or Episodic Migraine

Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention

Start date: September 6, 2017
Phase: Phase 2
Study type: Interventional

To evaluate the effect of AMG 301 compared to placebo on the change from the baseline period in monthly migraine days in subjects with migraine.